Human Health Holdings Limited

HKEX:1419.HK

0.83 (HKD) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q32015 Q22015 Q12014 Q1
Revenue 295.19320.472681.274733.249388.544424.048230.664198.932254.805275.439253.146264.658253.362247.263233.884269.973134.987117.817110.78684.252
Cost of Revenue 187.8234.072249.327322.315202.867188.598122.501127.437138.072148.833132.318139.092135.354131.775123.212140.70870.35461.90359.41547.752
Gross Profit 107.3986.4431.947410.934185.677235.45108.16371.495116.733126.606120.828125.566118.008115.488110.672129.26564.63355.91451.37136.5
Gross Profit Ratio 0.3640.270.6340.560.4780.5550.4690.3590.4580.460.4770.4740.4660.4670.4730.4790.4790.4750.4640.433
Reseach & Development Expenses 00000000000000000000
General & Administrative Expenses 28.043180.53330.651144.08422.61985.92266.4522.642110.45105.394105.331134.0269.67666.55969.95269.09234.54641.22945.33433.204
Selling & Marketing Expenses 60.86-34.99735.092-27.05227.60105.32873.678-0.0140.0240-15.75215.75216.71315.2615.26115.261000
SG&A 88.903110.539100.842101.02977.785.922111.62796.32110.436105.418105.331102.517101.17999.985100.47199.61349.80741.22945.33433.204
Other Expenses 00000000000000000-6.6800
Operating Expenses 88.903110.539100.842101.02977.785.922111.62796.32110.436105.418107.257107.524104.631103.272103.228108.57154.28540.22744.91233.112
Operating Income 18.487-24.139331.105309.905107.977149.528-3.464-24.8256.29721.18814.69122.24416.02314.6979.39530.45815.22915.7126.4643.416
Operating Income Ratio 0.063-0.0750.4860.4230.2780.353-0.015-0.1250.0250.0770.0580.0840.0630.0590.040.1130.1130.1330.0580.041
Total Other Income Expenses Net 6.207-61.769-4.83828.720.6370.11921.647-17.721-1.62-0.681-0.475-3.99-2.491-2.291-1.704-9.698-4.849-7.101-0.0370
Income Before Tax 24.694-85.908326.267338.625108.614149.64718.183-42.5464.67720.50714.21618.25413.53212.4067.69120.7610.388.6116.4273.416
Income Before Tax Ratio 0.084-0.2680.4790.4620.280.3530.079-0.2140.0180.0740.0560.0690.0530.050.0330.0770.0770.0730.0580.041
Income Tax Expense 3.9010.99756.9852.15517.79822.9691.3980.7110.6514.7583.6184.8683.7534.1843.3226.3843.1924.1251.8580.726
Net Income 20.033-87.273268.112284.88190.428127.55916.894-43.5183.14415.74910.87513.82710.2848.7854.68414.3767.1884.4864.5692.652
Net Income Ratio 0.068-0.2720.3940.3890.2330.3010.073-0.2190.0120.0570.0430.0520.0410.0360.020.0530.0530.0380.0410.031
EPS 0.053-0.230.710.750.240.340.045-0.110.0080.0420.030.0380.0280.0240.0130.0460.0230.0130.0130.008
EPS Diluted 0.053-0.230.710.750.240.340.045-0.110.0080.0420.030.0380.0280.0240.0130.0460.0230.0130.0130.008
EBITDA 51.60314.857366.998343.161137.795181.79831.86413.17843.62727.40920.65327.58920.97619.81713.56334.78217.39118.0188.5074.798
EBITDA Ratio 0.1750.0460.5390.4680.3550.4290.1380.0660.1710.10.0820.1040.0830.080.0580.1290.1290.1530.0770.057